Valuation : Illumina, Inc.

Market Cap 31.17B 26.86B 25.43B 23.05B 43.25B 2,978B 43.47B 302B 116B 1,515B 117B 115B 4,788B P/E 2026 *
41.7x
P/E 2027 * 35.3x
Enterprise Value 31.06B 26.76B 25.34B 22.97B 43.09B 2,967B 43.3B 301B 116B 1,510B 117B 114B 4,770B EV / Sales 2026 *
6.72x
EV / Sales 2027 * 6.14x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day+2.57%
1 week-5.39%
Current month-3.36%
1 month+7.06%
3 months+24.21%
6 months+69.92%
Current year+57.40%
1 week 200.01
Extreme 200.01
219.45
1 month 187.44
Extreme 187.44
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
461.08
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

General Counsel

29,377 0.0195%
05/09/26 Tax

Chief Technology Officer

-408 0.0003%
04/09/26
Corvex Management LP
SellCompany -119,501 0.0791%
Change 5-day change 1-year change 3-year change Capi.($)
+2.57%-5.39%+107.88%+33.41% 31.17B
+1.10%-0.65%+24.10%+18.43% 225B
-0.19%-3.62%+2.55%-20.00% 141B
+2.41%+0.67%-19.02%+22.09% 130B
-0.28%-10.08%-58.81%-21.22% 62.29B
-2.77%-6.15%+8.15%+12.69% 48.63B
-0.49%-1.97%-20.35%-15.53% 49.39B
+2.66%-2.61%+15.94%+29.91% 41.42B
+1.67%-0.25%+35.01%+55.09% 40.12B
-0.60%-4.41%-20.52%+44.06% 31.23B
Average +0.61%-4.00%+7.49%+15.89% 80.08B
Weighted average by Cap. +0.60%-2.76%+4.78%+10.76%

Financials

2026 *2027 *
Net sales 4.62B 3.98B 3.77B 3.42B 6.41B 442B 6.45B 44.8B 17.23B 225B 17.37B 16.98B 710B 4.92B 4.24B 4.01B 3.64B 6.82B 470B 6.85B 47.64B 18.32B 239B 18.46B 18.06B 755B
Net income 768M 661M 626M 568M 1.06B 73.33B 1.07B 7.44B 2.86B 37.31B 2.88B 2.82B 118B 899M 774M 733M 665M 1.25B 85.85B 1.25B 8.71B 3.35B 43.68B 3.38B 3.3B 138B
Net Debt -116M -99.6M -94.31M -85.49M -160M -11.04B -161M -1.12B -431M -5.62B -434M -425M -17.76B -976M -841M -796M -722M -1.35B -93.25B -1.36B -9.46B -3.64B -47.44B -3.67B -3.59B -150B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
11/09/26 $206.45 +2.57% 2,412,436
10/09/26 $201.27 -1.82% 1,294,628
09/09/26 $205.00 -2.87% 1,707,641
08/09/26 $211.06 -3.28% 1,820,155
04/09/26 $218.22 -1.55% 1,748,198
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
206.45USD
Average target price
202.65USD
Spread / Average Target
-1.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!